InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Discover the full record of transactions filed by McCarthy Sean A., Chief Executive Officer. Insider active across 1 companies, notably CytomX Therapeutics, Inc.. Cumulatively, 11 reports have been logged. Total volume traded: €1.2m. The latest transaction was filed on 9 May 2022 — Levée d'options. Regulator: SEC (Form 4). All data is free.
Declarations11 total
€59,69466,742 shares@ €0.89440.0082% mcap4.2% of flow
Common Stock
SEC:0001567619-22-010091:0·
075,000 shares0
Common Stock
SEC:0001567619-22-002521·
075,000 shares0
Common Stock
SEC:0001567619-22-002521:0·
€88,95292,113 shares@ €0.96570.012% mcap13.2% of flow
Common Stock
SEC:0001567619-21-015554·
€88,95292,113 shares@ €0.96570.012% mcap6.3% of flow
Common Stock
SEC:0001567619-21-015554:0·
€587,274100,000 shares@ €5.87270.081% mcap86.8% of flow
Common Stock
SEC:0001567619-21-012419·
€587,274100,000 shares@ €5.87270.081% mcap41.6% of flow
Common Stock
SEC:0001567619-21-012419:0·
€2830 shares@ €0.93540.0000% mcap0.0% of flow
Common Stock
SEC:0001567619-21-012252·
€2830 shares@ €0.93540.0000% mcap0.0% of flow
Common Stock
SEC:0001567619-21-012252:0·
04,500 shares0
Common Stock
SEC:0001567619-21-011808·
04,500 shares0
Common Stock
SEC:0001567619-21-011808:0·
11 of 11 declarations
About McCarthy Sean A.
McCarthy Sean A. serves as President and CEO at CytomX Therapeutics, Inc. He is responsible for the strategic direction of the company and overseeing operations. His role is essential in ensuring the growth and performance of the company in the biopharmaceutical sector.
